Article Details
Retrieved on: 2021-08-18 12:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... GMP capacity but also very importantly the initial R&D and process optimization phases capabilities," a spokesperson told BioPharma-Reporter.
Article found on: www.biopharma-reporter.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here